Insys Ch. 11 Sale Of Controversial Drug OK'd With New Limits
Insys Therapeutics Inc. received bankruptcy court approval Thursday in Delaware for a sale of its controversial pain medication Subsys after the buyer agreed to limit its marketing and distribution efforts to...To view the full article, register now.
Already a subscriber? Click here to view full article